Reaction Biology Corp.
RBC is a contract research organization specializing in kinase and epigenetic HTS and profiling. We also own a protein production facility which provides high quality epigenetic proteins to the drug discovery industry.
RBC provides flexible customized product development, assay development and collaborative research to address each customers’ individual problems.
Every protein RBC produces is tested with different techniques to ensure the activity, conformation, and purity. Unlike several other providers, we do not sell protein simply based on purity alone. Assays offered by RBC hold optimized assay conditions for data reproducibility. All assays are validated with common tool compounds.
RBC’s scientists are highly experienced in the field of histone methyltransferases and epigenetic post-translational modifications in general. They can offer insight into your epigenetic projects. We have a track record of successful epigenetic publications from our customers and our own scientists.
Visit Our Website
It’s All About “Me”: Making and Assaying Active Histone Methyltransferases
October 06 by Pharma IQPlease note that this webinar is now available on demand. Login to view. Histone Methyltransferases (HMTs) are emerging as new targets for drug discovery at a time when our knowledge of how these...
Read and Destroy: RBC’s Tools for Bromodomains and Demethylases
June 17 by Pharma IQEpigenetic enzymes control gene expression through highly dynamic and reversible processes essential to normal cellular function. Malfunctions of these enzymes are implicated in a number of cancers, i...
RBC’s Epigenetics Toolbox: Enabling Epigenetic Research and Drug Discovery
November 20 by Pharma IQEpigenetic enzymes control the mechanics of genetic expression, acting as "on" and "off" switches for the human genome. Malfunctions of these enzymes are implicated in a number of cancer, immunologic...
